Studies in rodents and humans (Chaldakov et al., 2004; Motamedi et al., 2017) have shown that low levels of circulating BDNF are associated with metabolic dysfunctions such as obesity, metabolic syndrome and related disorders (e.g., diabetes, cardiovascular disease). This evidence concerns the gene BDNF and metabolic syndrome.